Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers in Clinical Samples from Botswana

The American Journal of Tropical Medicine and Hygiene
Leabaneng TaweGiacomo M Paganotti

Abstract

Drug-resistant Plasmodium falciparum is a major threat to global malaria control and elimination efforts. In Botswana, a southern African country approaching malaria elimination, P. falciparum molecular data are not available. Parasites were assessed through pollymerase chain reaction (PCR) for confirmation of positive rapid diagnostic tests, multiplicity of infection (MOI), and drug resistance markers among isolates from clinical uncomplicated malaria cases collected at health facilities. Of 211 dried blood spot samples selected for the study, 186 (88.2%) were PCR positive for P. falciparum. The mean MOI based on MSP1 genotyping was 2.3 and was not associated with age. A high prevalence of wild-type parasites for pfcrt and pfmdr1 was found, with a haplotype frequency (K76/N86) of 88.8% and 17.7% of the isolates having two copies of the pfmdr1 gene. For pfATPase6, all the parasites carried the wild-type S769 allele. Sequencing showed no evidence of non-synonymous mutations associated with reduced artemisinin derivative sensitivity in the P. falciparum k13 gene. In conclusion, we found that P. falciparum parasites in Botswana were mostly wild type for the drug resistance markers evaluated. Yet, there was a high rate of a molecul...Continue Reading

References

May 20, 1987·Journal of Molecular Biology·Kazuyuki TanabeJ G Scaife
Jan 1, 1995·The American Journal of Tropical Medicine and Hygiene·Francine NtoumiOdile Mercereau-Puijalon
Feb 15, 2001·The New England Journal of Medicine·Abdoulaye A DjimdeChristopher V Plowe
Apr 9, 2002·The Lancet Infectious Diseases·Chansuda WongsrichanalaiSteven R Meshnick
Jun 7, 2003·The Journal of Infectious Diseases·James G KublinChristopher V Plowe
Oct 20, 2005·The Journal of Infectious Diseases·Anne-Catrin UhlemannSanjeev Krishna
Apr 21, 2010·Antimicrobial Agents and Chemotherapy·Benoit WitkowskiAntoine Berry
Feb 22, 2012·Expert Review of Anti-infective Therapy·Raquel GonzálezAlfredo Mayor
Nov 28, 2012·Japanese Journal of Infectious Diseases·Toshihiro Mita, Kazuyuki Tanabe
Dec 24, 2013·Malaria Journal·Chihanga SimonUbydul Haque
Sep 4, 2014·Asian Pacific Journal of Tropical Biomedicine·Kanungnit CongpuongAibteesam Dornae
Jan 20, 2015·Nature Genetics·Olivo MiottoDominic P Kwiatkowski
Mar 11, 2015·Antimicrobial Agents and Chemotherapy·Patrick TumwebazePhilip J Rosenthal
Nov 21, 2015·PLoS Neglected Tropical Diseases·Rosalind E HowesSimon I Hay
Jan 7, 2016·Nature Structural & Molecular Biology·Stéphanie David-BosneMarc le Maire
Feb 26, 2016·Parasites & Vectors·Simon ChihangaGregory E Glass

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.